CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

KU Leuven - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/education

education organization

KU Leuven

BE

OPENALEX: I99464096↗ROR: 05f950310↗

People

Connected researchers

Henry OtgaarORCID 0000-0002-2782-2181 Jan M. Van KeerORCID 0000-0003-4490-5170 Jenny CeccariniORCID 0000-0003-2774-9516 Koen Van LaereORCID 0000-0001-5200-7245 Lukas Van OudenhoveORCID 0000-0002-6540-3113 Nathalie WeltensORCID 0000-0002-9596-8000 Ruud van WinkelORCID 0000-0001-6262-1935

Public evidence

6 connected articles

Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans.2019 · Europe PMC False memory formation in cannabis users: a field study.2019 · PubMed Central Open Access Cannabis-Induced Third-Degree AV Block.2019 · PubMed Central Open Access Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis.2019 · PubMed Central Open Access Further Evidence That Cannabis Moderates Familial Correlation of Psychosis-Related Experiences2015 · PubMed Central Open Access Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: 18F-Fallypride Positron Emission Tomography Study2013 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.